Our survival analysis of 890 TCGA breast cancer patient samples revealed that amongst the 139 patients with basal-like breast cancer tumors, high annexin A1 mRNA expression was associated with significantly shorter 5-year overall survival than patients with low annexin A1 expressing basal tumors (Fig 1A). This evidence concerns the gene ANXA1 and breast cancer.